Sjogrens Syndrome
164
31
40
79
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
14 trials with published results (9%)
Research Maturity
79 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.5%
9 terminated out of 164 trials
89.8%
+3.2% vs benchmark
10%
17 trials in Phase 3/4
18%
14 of 79 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 79 completed trials
Clinical Trials (164)
Nipocalimab in Moderate to Severe Sjogren's Disease
Sjogren's Mini-Pill Oral and Gut Microbiome Study
Characterization of Diseases With Salivary Gland Involvement
The Pathogenesis and Natural History of Sjogren's Disease
A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases
Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome
Comprehensive Evaluation of Clinical and Biopsychosocial Characteristics in Primary Sjögren's Disease
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome
A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome
Wheat-free Diet in the Treatment of Sjogren's Syndrome
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
Immune Profile of Saliva and Serum of Patients With Primary Sjögren´s Syndrome
An AI Algorithm for Lymphocyte Focus Score of Minor Salivary Gland Biopsy Samples for Diagnosing Sjogren's Syndrome
Evaluation of the Prevalence of Functional Digestive Disorders During Primary Sjögren Gougerot Syndrome
Aerobic Exercise in Primary Sjögren's Syndrome
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease